JUANA
GIL HERRERA
Profesora asociada de Ciencias de la Salud
Argitalpenak (24) JUANA GIL HERRERA argitalpenak
2024
-
Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputation
Blood, Vol. 143, Núm. 10, pp. 872-881
2023
-
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
Genome Medicine, Vol. 15, Núm. 1
2022
-
More difficult still: Treating severe rapidly progressive glomerulonephritis in the context of COVID-19 pneumonia
Nefrologia, Vol. 42, Núm. 1, pp. 94-98
2021
-
Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations
Journal of Allergy and Clinical Immunology, Vol. 148, Núm. 5, pp. 1332-1341.e5
-
Lymphocyte subsets early predict mortality in a large series of hospitalized COVID-19 patients in Spain
Clinical and Experimental Immunology, Vol. 203, Núm. 3, pp. 424-432
-
Next Generation Sequencing for Detecting Somatic FAS Mutations in Patients With Autoimmune Lymphoproliferative Syndrome
Frontiers in Immunology, Vol. 12
-
The age again in the eye of the COVID-19 storm: evidence-based decision making
Immunity and Ageing, Vol. 18, Núm. 1
2020
-
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Science, Vol. 370, Núm. 6515
-
Executive Summary of the Consensus Document on the Diagnosis and Management of Patients with Primary Immunodeficiencies
Journal of Allergy and Clinical Immunology: In Practice, Vol. 8, Núm. 10, pp. 3342-3347
-
Executive Summary of the Consensus Document on the Diagnosis and Management of Patients with Primary Immunodeficiencies
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 9, pp. 438-443
-
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Science, Vol. 370, Núm. 6515
2019
-
Multi-centre validation of a flow cytometry method to identify optimal responders to interferon-beta in multiple sclerosis
Clinica Chimica Acta, Vol. 488, pp. 135-142
-
Primary and secondary immunodeficiency diseases in oncohaematology: Warning signs, diagnosis, and management
Frontiers in Immunology, Vol. 10, Núm. MAR
-
Recommendations for the management of hemophagocytic lymphohistiocytosis in adults
Blood, Vol. 133, Núm. 23, pp. 2465-2477
2018
-
Acquired angioedema with anti–C1-inhibitor autoantibodies during assisted reproduction techniques
Journal of Investigational Allergology and Clinical Immunology
2017
-
Primary T-cell immunodeficiency with functional revertant somatic mosaicism in CD247
Journal of Allergy and Clinical Immunology, Vol. 139, Núm. 1, pp. 347-349.e8
2016
-
A case of IL-7R deficiency caused by a novel synonymous mutation and implications for mutation screening in SCID diagnosis
Frontiers in Immunology, Vol. 7, Núm. OCT
-
Multicenter study for the evaluation of the antibody response against salmonella typhi Vi vaccination (EMPATHY) for the diagnosis of Anti-polysaccharide antibody production deficiency in patients with primary immunodeficiency
Clinical Immunology, Vol. 169, pp. 80-84
2013
-
Sequential combined therapy with Omalizumab and Rituximab: A new approach to severe atopic dermatitis
Journal of Investigational Allergology and Clinical Immunology, Vol. 23, Núm. 3, pp. 190-196
2009
-
Association of monoclonal expansion of Epstein-Barr virus-negative CD158a+ NK cells secreting large amounts of gamma interferon with hemophagocytic lymphohistiocytosis
Clinical and Vaccine Immunology, Vol. 16, Núm. 1, pp. 142-145